Ask AI
ProCE Banner Activity

POLCAGB: Phase II/III Trial of Neoadjuvant Chemotherapy vs Neoadjuvant Chemoradiotherapy in Locally Advanced Gallbladder Cancer

Conference Coverage
Slideset

In phase II/III POLCAGB study, neoadjuvant chemoradiation plus chemotherapy vs chemotherapy alone yielded improved downstaging outcomes, surgical resection, and prolonged event-free and overall survival in patients with locally advanced or borderline resectable gallbladder cancer.

Released: June 10, 2025

Expiration: December 09, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Daiichi Sankyo, Inc. and Genentech, a member of the Roche Group.

Daiichi Sankyo, Inc.

Genentech, a member of the Roche Group